STOCK TITAN

Grayscale Stellar Lumens (GXLM) Financials

GXLM OTC
Trailing 12 months to June 30, 2026
Revenue Not reported for the trailing 12 months
Net Income -$7.3M -142.7% YoY
EPS (Diluted) Not reported for the trailing 12 months
Free Cash Flow Not reported for the trailing 12 months
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD FYE September

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 4, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the GXLM SEC filings page.

This page shows Grayscale Stellar Lumens (GXLM) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI GXLM FY2025

The trust’s reported assets and income move together across years, with FY2025 marking a sharp expansion after earlier contraction.

The notable pattern is that FY2025’s $30.5M net income arrived alongside assets of $43.1M, after FY2024’s $1.6M net loss and $10.6M of assets. That pairing makes the latest result look more like a sharp change in the trust’s reported asset base and accounting outcome than a steady operating earnings progression.

From FY2022 through FY2024, assets remained within a narrow $8.2M–$10.6M band while each year posted a net loss. FY2025 broke that pattern: assets rose 307.4% and net income reached $30.5M, while missing revenue and cash-flow data prevent an operating-margin interpretation.

The balance sheet is unusually simple: total liabilities were $0 in every reported year, so total assets and total equity moved identically; FY2025 equity reached $43.1M after 28.4% growth in FY2024. The supplied statements therefore show an expansion not funded by reported liabilities, but do not identify the mechanism behind the asset changes.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

We do not publish a peer-relative financial health score for Grayscale Stellar Lumens, because the score only covers companies whose filings and listing give us what it needs to compare them with their peers. The metrics below are current.

Key Financial Metrics

Export CSV

Earnings & Revenue

Net Income
$1.9M
YoYn/m
QoQn/m

Grayscale Stellar Lumens reported $1.9M in net income in Q2 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Revenue

Not reported for Q2 2026.

EBITDA

Not reported for Q2 2026.

EPS (Diluted)

Not reported for Q2 2026.

Cash & Balance Sheet

Shares Outstanding
1M
YoY+2.5%
QoQ+0.6%

Grayscale Stellar Lumens had 1M shares outstanding in Q2 2026. This represents an increase of 2.5% from the same quarter a year earlier. Against the prior quarter it is up 0.6%.

Free Cash Flow

Not reported for Q2 2026.

Cash & Debt

Not reported for Q2 2026.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Return on Equity
8.9%
YoY+34.7pp
QoQ+27.9pp

Grayscale Stellar Lumens's quarterly ROE was 8.9% in Q2 2026: one quarter's net income over shareholder equity, not annualized. This is up 34.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 27.9 percentage points.

Gross Margin

Not reported for Q2 2026.

Operating Margin

Not reported for Q2 2026.

Net Margin

Not reported for Q2 2026.

Capital Allocation

None of these metrics is reported for Q2 2026.

GXLM Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

GXLM quarterly income statement
MetricQ2'2610-QQ1'2610-QQ4'2510-KQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-KQ4'2410-K
Net Income$1.9Mn/m-$3.7M-113.8%-$19.9M-2342.4%$14.4M+1523.8%-$2.8Mn/m-$8.1M-1001.7%$27.0M+2271.4%$887Kn/m

Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Interest Expense, Income Tax, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).

GXLM Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

GXLM quarterly balance sheet
MetricQ2'2610-QQ1'2610-QQ4'2510-KQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-KQ4'2410-K
Total Assets$21.8M-30.5%$19.6M-50.3%$23.2M+119.3%$43.1M+307.4%$28.5M+227.1%$31.3M+170.2%$39.4M+316.9%$10.6M+28.4%
Total Liabilities$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m
Total Equity$21.8M-30.5%$19.6M-50.3%$23.2M+119.3%$43.1M+307.4%$28.5M+227.1%$31.3M+170.2%$39.4M+316.9%$10.6M+28.4%

Not reported in any period shown, so not listed: Current Assets, Cash & Equivalents, Short-Term Investments, Inventory, Accounts Receivable, Long-Term Investments, Goodwill, Current Liabilities, Non-Current Liabilities, Long-Term Debt, Retained Earnings.

GXLM Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

GXLM quarterly financial ratios
MetricQ2'2610-QQ1'2610-QQ4'2510-KQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-KQ4'2410-K
Return on Equity8.9%+34.7pp-19.0%-87.4pp-85.8%-94.2pp33.4%+25.0pp-9.8%+41.9pp-25.8%-33.5pp68.5%+56.4pp8.4%+8.8pp
Return on Assets8.9%+34.7pp-19.0%-87.4pp-85.8%-94.2pp33.4%+25.0pp-9.8%+41.9pp-25.8%-33.5pp68.5%+56.4pp8.4%+8.8pp
Liabilities-to-Equity0.000.0x0.000.0x0.000.0x0.000.0x0.000.0x0.000.0x0.000.0x0.000.0x

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Current Ratio, Debt-to-Equity, Asset Turnover, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Grayscale Stellar Lumens GXLM FY2025 N/A $30.5M N/A N/A —
Grayscale Bitcoin Cash TR BCHG FY2026 N/A -$126.4M N/A N/A —
Grayscale Litecoin TR LTC LTCN FY2026 N/A -$93.6M N/A N/A —
Grayscale Ethrm Clssic TR ETCG FY2025 N/A -$157.1M N/A N/A —
Grayscale Horizen TR ZEN HZEN FY2025 N/A -$3.9M N/A N/A —
Janel Corp JANL FY2025 $207.4M $5.7M 2.7% $51.0M —

Frequently Asked Questions

No, Grayscale Stellar Lumens (GXLM) reported a net loss of $7.3M over the trailing 12 months to June 30, 2026. In fiscal year 2025 it reported a net income of $30.5M.

Grayscale Stellar Lumens (GXLM) has a return on equity of 70.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Grayscale Stellar Lumens (GXLM) had $43.1M in total assets as of fiscal year 2025, including both current and long-term assets.

Grayscale Stellar Lumens (GXLM) had 1M shares outstanding as of fiscal year 2025.

Grayscale Stellar Lumens (GXLM) had a liabilities-to-equity ratio of 0.00 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity. No debt-to-equity ratio is shown for fiscal year 2025, because the filing data we hold for that year carries no long-term debt figure.

Grayscale Stellar Lumens (GXLM) had a return on assets of 70.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Back to top